Endocrine-related cancer

Label

• Endocrine-related cancer (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Clinico-pathological significance of cell-type specific loss of heterozygosity (LOH) on chromosome 7q21: analysis of 318 microdissected thyroid lesions. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Cellular and molecular crosstalk between leptin receptor and estrogen receptor-± in breast cancer: molecular basis for a novel therapeutic setting. (Articolo in rivista) (Prodotto della ricerca)
• The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. (Articolo in rivista) (Prodotto della ricerca)
• Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice. (Articolo in rivista) (Prodotto della ricerca)
• The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. (Articolo in rivista) (Prodotto della ricerca)
• Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Role of PTPRJ genotype in the risk for papillary thyroid carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
• Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474. (Articolo in rivista) (Prodotto della ricerca)
• Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• MicroRNAs: a great challenge for the diagnosis and therapy of endocrine cancers. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• MicroRNA deregulation in human thyroid papillary carcinomas. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• BRAF(V600E) mutation and the biology of papillary thyroid cancer (Articolo in rivista) (Prodotto della ricerca)
• Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. (Articolo in rivista) (Prodotto della ricerca)
• FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. (Articolo in rivista) (Prodotto della ricerca)
• Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Endocannabinoids in endocrine and related tumours. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Metformin, cancer and glucose metabolism. (Articolo in rivista) (Prodotto della ricerca)

Alternative label

• Endocrine-related cancer. (literal)
• Endocr.-relat. cancer (literal)

Language

• eng (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn

• 1351-0088 (literal)

Preferred label

• Endocrine-related cancer (literal)

Publisher

• BioScientifica Bristol : GBR (literal)

Incoming links:

Rivista

• BRAF(V600E) mutation and the biology of papillary thyroid cancer (Articolo in rivista) (Prodotto della ricerca)
• MicroRNA deregulation in human thyroid papillary carcinomas. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. (Articolo in rivista) (Prodotto della ricerca)
• Endocannabinoids in endocrine and related tumours. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Cellular and molecular crosstalk between leptin receptor and estrogen receptor-± in breast cancer: molecular basis for a novel therapeutic setting. (Articolo in rivista) (Prodotto della ricerca)
• Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice. (Articolo in rivista) (Prodotto della ricerca)
• The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. (Articolo in rivista) (Prodotto della ricerca)
• Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• MicroRNAs: a great challenge for the diagnosis and therapy of endocrine cancers. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Clinico-pathological significance of cell-type specific loss of heterozygosity (LOH) on chromosome 7q21: analysis of 318 microdissected thyroid lesions. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. (Articolo in rivista) (Prodotto della ricerca)
• Role of PTPRJ genotype in the risk for papillary thyroid carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
• Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474. (Articolo in rivista) (Prodotto della ricerca)
• PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. (Articolo in rivista) (Prodotto della ricerca)
• Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Metformin, cancer and glucose metabolism. (Articolo in rivista) (Prodotto della ricerca)